Search Within

David H Ilson

Formats
  1. Journal Article (210)
  2. Meeting Abstract (169)
  3. Book Section (20)
  4. Review (14)
  5. Editorial (9)
  6. Conference Paper (6)
  7. Guidelines (3)
  8. Correspondence (2)
  9. Book Whole (1)
  10. Miscellaneous (1)
  11. Research Letter (1)
Groups
  1. Department of Medicine (436)
  2. Gastrointestinal Oncology Service (436)
  3. Solid Tumor Oncology Division (436)
  4. Center for Pancreatic Cancer Research (187)
  5. Surgery (137)
  6. Survivorship Research (127)

More Groups

People
  1. David Kelsen (132)
  2. Geoffrey Ku (123)
  3. Yelena Janjigian (112)
  4. Marinela Capanu (65)
  5. Laura Tang (60)
  6. Manjit Bains (51)

More People

Years
  1. 2025 (8)
  2. 2024 (16)
  3. 2023 (24)
  4. 2022 (21)
  5. 2021 (22)
  6. 2020 (20)

More Years

Publications
  1. Journal of Clinical Oncology (135)
  2. Annals of Oncology (28)
  3. International Journal of Radiation Oncology, Biology, Physics (15)
  4. Journal of the National Comprehensive Cancer Network (14)
  5. Annals of Surgical Oncology (13)
  6. Cancer (12)

More Publications

Publishers
  1. American Society of Clinical Oncology (137)
  2. Elsevier Inc. (59)
  3. Oxford University Press (41)
  4. Springer (32)
  5. Lippincott Williams & Wilkins (22)
  6. Wiley Blackwell (19)

More Publishers

Results (436)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adjuvant nivolumab in esophageal cancer: A new standard of care
    Editorial

    Ilson, D. H.
    New England Journal of Medicine (2021)

    Fulltext@MSK | Save
  • Cancer of the esophagus
    Book Section

    Ku, G. Y.; Ilson, D. H.
    In Niederhuber, J. E.; Armitage, J. O.; Kastan, M. B.; Doroshow, J. H.; Tepper, J. E. (Eds.) Abeloff’s Clinical Oncology. 6th ed (2020)

    Fulltext@MSK | Save
  • Cancer of the stomach
    Book Section

    Ku, G. Y.; Ilson, D. H.
    In Niederhuber, J. E.; Armitage, J. O.; Kastan, M. B.; Doroshow, J. H.; Tepper, J. E. (Eds.) Abeloff’s Clinical Oncology. 6th ed (2020)

    Fulltext@MSK | Save
  • Phase III study of first-line zolbetuximab plus CAPOX versus placebo plus CAPOX in Claudin 18.2(+)/HER2(-) advanced or metastatic gastric or gastroesophageal junction adenocarcinoma: GLOW
    Meeting Abstract

    Shah, M. A.; Ajani, J. A.; Al-Batran, S. E.; Bang, Y. J.; Catenacci, D.; Enzinger, P. C.; Ilson, D. H.; Kim, S.; Lordick, F.; Shitara, K.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • SPOTLIGHT: Phase III study of zolbetuximab + mFOLFOX6 versus placebo + mFOLFOX6 in first-line Claudin18.2(+)/HER2(-) advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (G/GEJ)
    Meeting Abstract

    Shitara, K.; Al-Batran, S. E.; Bang, Y. J.; Catenacci, D.; Enzinger, P. C.; Ilson, D. H.; Kim, S.; Lordick, F.; Shah, M. A.; van Cutsem, E.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • GLOW: Phase III study of first-line zolbetuximab + CAPOX versus placebo + CAPOX in Claudin18.2(+)/HER2(-) advanced/metastatic gastric or gastroesophageal junction adenocarcinoma (G/GEJ)
    Meeting Abstract

    Xu, R. H.; Ajani, J. A.; Al-Batran, S. E.; Bang, Y. J.; Catenacci, D.; Enzinger, P. C.; Ilson, D. H.; Kim, S.; Lordick, F.; Shitara, K.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Survival and patterns of failure in oligometastatic esophagogastric cancer
    Meeting Abstract

    Hilal, L.; Ku, G.; Molena, D.; Janjigian, Y.; Ilson, D. H.; Maron, S.; Sihag, S.; Yoon, S. S.; Strong, V.; Crane, C. H.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Millang, B. M.; Sabwa, S.; Chou, J. F.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • PD-L1 positive esophagogastric (EG) cancer is associated with distinct bacteria
    Meeting Abstract

    Maron, S. B.; Vanderbilt, C.; Sabwa, S.; Bowman, A.; Chatila, W. K.; Tang, L. H.; Strong, V. E.; Molena, D.; Jones, D. R.; Coit, D. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • PET-directed chemoradiation (CRT) with induction FOLFOX compared to induction carboplatin/paclitaxel (CP) in patients with locally advanced esophageal adenocarcinoma (EA)
    Meeting Abstract

    Carr, R.; Hsu, M.; Tan, K. S.; Bains, M. S.; Bott, M.; Ilson, D. H.; Isbell, J. M.; Janjigian, Y. Y.; Maron, S. B.; Park, B.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save